Treatment options in type-2 low asthma

Monoclonal antibodies targeting IgE or the type-2 cytokines IL-4, IL-5 and IL-13 are proving highly effective in reducing exacerbations and symptoms in people with severe allergic and eosinophilic asthma respectively. However, these therapies are not appropriate for 30–50% of patients in severe asth...

全面介绍

书目详细资料
Main Authors: Hinks, TSC, Levine, SJ, Brusselle, GG
格式: Journal article
语言:English
出版: European Respiratory Society 2020